Avrobio Inc reported $-27774000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Akebia Therapeutics AKBA:US USD -47994000 96.43M
Alnylam Pharmaceuticals ALNY:US USD -258040000 66.35M
Bluebird Bio BLUE:US USD -86480000 14.28M
Gilead Sciences GILD:US USD 2.81B 784M
Intercept Pharmaceuticals ICPT:US USD -10144000 3.22M
Karyopharm Therapeutics KPTI:US USD -30839000 12.07M
Macrogenics MGNX:US USD -24955000 16.85M
Pfizer PFE:US USD 9.7B 2.43B
Roche Holding ROG:VX 11.54B 2.84B
Sangamo Biosciences SGMO:US USD -54894000 9.16M
Sarepta Therapeutics SRPT:US USD -131355000 79.78M
Takeda 4502:JP JPY 104.44B 46.08B